Antibody engineering: the importance of collaboration and successful partnerships
The Drug Discovery World Podcast
Release Date: 07/16/2021
What’s at the forefront of innovation?
The Drug Discovery World Podcast
This is the latest episode of the free DDW podcast, “What’s at the forefront of innovation?” It covers three articles written for the for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “”, “”, and “”. In the first article, Lu Rahman spoke to Ashley Zehnder, CEO of Fauna Bio, a biotech harnessing the power of comparative and functional animal genomics to find better therapies for human disease, including neurologic, metabolic, fibrotic and cardiovascular disorders. In the second article, Chiedzo Mpofu, Vice President, Global Medical Affairs Head,...
info_outline
DDW Highlights: 22 May 2023
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. It was recently Clinical Trials Day and DDW have reported on the launch of a number of new Phase I trials. In-human studies have been initiated to test treatments for Parkinson’s disease, radioactive contamination, Dravet Syndrome, influenza and inflammatory diseases. You can listen below, or find The Drug Discovery World Podcast on , and
info_outline
How precision medicine will transform clinical trials
The Drug Discovery World Podcast
In theseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this latest episode, DDW's Megan Thomas is in conversation with Dr Michael Pace, Global & Strategic Feasibility Expert at Rho. Leveraging historical trial databases has become commonplace in assessing the feasibility of trials in therapeutic areas with a large breadth of clinical development history. In the future, clinical trials are going to come down to the patient level, similar to how...
info_outline
DDW Highlights: 9 May 2023
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. DDW's Diana Spencer has selected five stand-out news headlines this week, which all relate to immunotherapy or immunomodulatory therapies for cancer, particularly advances in our understanding of how other factors in the body, i.e., vitamin D levels and the gut microbiome, can impact the patient’s response to treatment. You can listen below, or find The Drug Discovery World Podcast...
info_outline
DDW Highlights: 2 May 2023
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Each of our top five stories this week exemplify the scientific curiosity that fuels the drug discovery sector, ultimately leading to better treatments for patients. The stories cover the efforts by research teams to discover innovative novel drugs for geographic atrophy, HIV, lung cancer, anxiety and diabetes. You can listen below, or find The Drug Discovery World Podcast...
info_outline
The impact of technology on drug discovery
The Drug Discovery World Podcast
This is the latest episode of the free DDW narrated podcast, “The impact of technology on drug discovery”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “” and “” With Covid-19 taking so much of the drug discovery and development’s focus over the last two years, it has been easy to overlook other areas within the sector that deserve our attention. So in the first article, Lu Rahman highlights the technology that will play a valuable role in the industry. Kizoo Technology Capital has a clear aim – to develop drugs that abate or...
info_outline
Disease X: The 100 Days Mission to End Pandemics
The Drug Discovery World Podcast
In theseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this latest episode, DDW's Megan Thomas is in conversation with Kate Kelland, author of Disease X: The 100 Days Mission to End Pandemics, which explores the emergence of the novel coronavirus and the crisis it caused. In this episode, Kelland shares what she means by the 'next pandemic', the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma...
info_outline
DDW Highlights: 24 April 2023
The Drug Discovery World Podcast
The latest episode of the is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news stories dominating the headlines this week have been the breaking developments in cancer drug discovery announced at the American Association of Cancer Research () Annual Meeting, which was held in Florida, US from 14-19 April. You can listen below, or find The Drug Discovery World Podcast on , and
info_outline
How Cancer Research Horizons is innovating through its academic and industry interface
The Drug Discovery World Podcast
The latest sponsored DDW Sitting Down With podcast features Steve Wedge, Chief Scientific Officer of Cancer Research Horizons and Mike Waring, Head of Academic Medicinal Chemistry at Cancer Research Horizons. They discuss the work Cancer Research Horizons is conducting at its site in Newcastle University; how Cancer Research Horizons operates within its academic/industry interface; how Newcastle University acts as an integrated academic partner; and some of the technical expertise and hit finding strategies being developed by the organisation.
info_outline
How a target safety assessment supports the drug development process
The Drug Discovery World Podcast
In the latest sponsored DDW Sitting Down With podcast Professor Ruth Roberts, Co-Founder ApconiX and Claire Sadler, Project Toxicologist, discuss the benefits of carrying out a target safety assessment (TSA) during drug discovery and development whenever a biological target is going to be The speakers outline how TSAs can be used throughout the drug discovery and development pathway and offer examples of best practice and potential next steps. Listen now.
info_outlineMathur talks about Twist’s antibody expertise, drawing on the company’s experience and looking at the importance of collaboration. The company has created some successful partnerships and she explains what these look like, why they have been fruitful, and how they have enabled Twist to use its capabilities to maximum effect.
Listen now to hear Mathur discuss the company philosophy, how the pandemic has affected the business, its partnership experience and what the future holds for this forward-thinking company.